Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Purple Biotech Ltd. Sponsored ADR (PPBT : NSDQ)
 
 • Company Description   
Purple Biotech Ltd. is a clinical-stage company focusing on therapies to overcome tumor immune evasion and drug resistance. The Company's oncology pipeline includes NT219 and CM24. Purple Biotech Ltd., formerly known as Kitov Pharma Ltd., is based in TEL AVIV, Israel.

Number of Employees: 19

 
 • Price / Volume Information   
Yesterday's Closing Price: $3.10 Daily Weekly Monthly
20 Day Moving Average: 64,133 shares
Shares Outstanding: 25.94 (millions)
Market Capitalization: $80.42 (millions)
Beta: 2.20
52 Week High: $6.75
52 Week Low: $2.44
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 1.97% 11.66%
12 Week 4.73% 17.70%
Year To Date -20.31% -2.64%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
4 OPPENHEIMER STREET SCIENCE PARK
-
REHOVOT,L3 7670104
ISR
ph: 972-3933-3121
fax: 972-3509-7196
ir@purple-biotech.com https://purple-biotech.com
 
 • General Corporate Information   
Officers
Isaac Israel - Chief Executive Officer and Director
Eric Rowinsky - Chairman
Gil Efron - President and Chief Financial Officer
Fabien Sebille - Chief Business Officer
Simcha Rock - Director

Peer Information
Purple Biotech Ltd. Sponsored ADR (CORR.)
Purple Biotech Ltd. Sponsored ADR (RSPI)
Purple Biotech Ltd. Sponsored ADR (CGXP)
Purple Biotech Ltd. Sponsored ADR (BGEN)
Purple Biotech Ltd. Sponsored ADR (GTBP)
Purple Biotech Ltd. Sponsored ADR (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 74638P109
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: -
Share - Related Items
Shares Outstanding: 25.94
Most Recent Split Date: 8.00 (0.10:1)
Beta: 2.20
Market Capitalization: $80.42 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: -  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.38
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -
12/31/21 - -
09/30/21 - -
Current Ratio
03/31/22 - 5.83
12/31/21 - 11.40
09/30/21 - 13.78
Quick Ratio
03/31/22 - 5.83
12/31/21 - 11.41
09/30/21 - 13.78
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - 2.25
12/31/21 - 2.51
09/30/21 - 2.67
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©